| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.7M | — |
| R&D Expense | $21.1M | -22.4% |
| SG&A Expense | $15.1M | -4.7% |
| Operating Income | -$25.5M | +44.2% |
| Income Tax | $0 | — |
| Net Income | -$63.6M | -47.7% |
| EPS (Basic) | -$21.67 | -1.6% |
| EPS (Diluted) | -$21.67 | -1.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -4.1% |
| Accounts Receivable | $2.0M | -5.3% |
| Current Assets | $38.9M | -5.3% |
| Total Assets | $48.5M | +5.2% |
| Current Liabilities | $7.3M | +2.3% |
| Total Liabilities | $69.8M | +757.5% |
| Stockholders' Equity | -$21.4M | -156.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.6M | +56.3% |
| Capital Expenditures | $26K | -93.5% |
| Investing Cash Flow | -$26K | -100.1% |
| Financing Cash Flow | $16.2M | +5760.9% |
| Free Cash Flow | -$17.7M | +56.7% |